(Q34278783)

1 August 2017

1 reference

title

Chronic heart failure and micronutrients (English)

1 reference

1 August 2017

0 references

chronic heart failure

1 reference

Witte KK

1

1 reference

1 August 2017

Clark AL

series ordinal

2

1 reference

1 August 2017

Cleland JG

series ordinal

3

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

Journal of the American College of Cardiology

1 August 2017

published in

1 reference

1 August 2017

volume

37

1 reference

1 August 2017

issue

7

1 reference

1 August 2017

page(s)

1765-1774

1 reference

The epidemiology of heart failure

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Recognising the limits of randomized clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Successes and failures of current treatment of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Trends in hospitalization for heart failure in Scotland 1980-1990.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Diseases of the heart in the works of Hippocrates

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Protein-energy malnutrition in patients with ischemic and nonischemic dilated cardiomyopathy and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Wasting as independent risk factor for mortality in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

THE PATHOGENESIS OF CARDIAC CACHEXIA

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Relation of daily activity levels in patients with chronic heart failure to long-term prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Heart failure in rats causes changes in skeletal muscle morphology and gene expression that are not explained by reduced activity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Increased resting metabolic rate in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Resting energy expenditure in chronic cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Daily energy requirements in heart failure patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Energy expenditure and symptom severity in men with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Catabolism in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Insulin resistance in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Elevated plasma levels of tumor necrosis factor in chronic heart failure with cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Nutritional assessment and muscle energy metabolism in severe chronic congestive heart failure--effects of long-term dietary supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Fat malabsorption in elderly patients with cardiac cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Micronutrients: highlights and research challenges from the 1994-5 National Diet and Nutrition Survey of people aged 65 years and over

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Aging decreases the capacity of human skin to produce vitamin D3

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Congestive heart failure caused by vitamin D deficiency?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Improvement of hypocalcemic cardiomyopathy by correction of serum calcium level

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Electrocardiographic Q-Tc prolongation associated with infusion of intravenous pamidronate disodium

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Hypocalcemic Torsades de Pointes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Ventricular fibrillation due to hypocalcemia after parathyroidectomy with autotransplantation of parathyroid tissue in a dialysis patient

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Bone Mass, Vitamin D Deficiency, and Hyperparathyroidism in Congestive Heart Failurefn1fn1This work was supported in part by Grants AR-41391 and RR-006645 from the National Institutes of Health

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Loss of bone mineral in patients with cachexia due to chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Plasma endothelin in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Experimental production of magnesium deficiency in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Prognostic importance of the serum magnesium concentration in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Clinical and prognostic significance of serum magnesium concentration in patients with severe chronic congestive heart failure: the PROMISE Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

The associations of levels of serum potassium and magnesium with ventricular premature complexes (the Framingham Heart Study)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Magnesium deficiency in adult rats promotes the induction of ventricular tachycardia by the administration of epinephrine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Effects of long-term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Ferrylmyoglobin formation induced by acute magnesium deficiency in perfused rat heart causes cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Decreased type VI adenylyl cyclase mRNA concentration and Mg(2+)-dependent adenylyl cyclase activities and unchanged type V adenylyl cyclase mRNA concentration and Mn(2+)-dependent adenylyl cyclase activities in the left ventricle of rats with myoca

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Hypomagnesaemia in elderly digitalised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Serum magnesium levels in symptomatic atrial fibrillation and their relation to rhythm control by intravenous digoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Dietary intake and nutritional status in regard to zinc of institutionalized aged

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Serum Levels of Selenium, Calcium, Copper Magnesium, Manganese and Zinc in Various Human Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Type II diabetes mellitus, congestive heart failure, and zinc metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Effect of zinc deficiency on lipid peroxidation status and infarct size in rat hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

The antioxidant function of metallothionein in the heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Zinc deficiency, ethanol, and myocardial ischemia affect lipoperoxidation in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Adriamycin-induced early changes in myocardial antioxidant enzymes and their modulation by probucol

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Weak antioxidant defenses make the heart a target for damage in copper-deficient rats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Increased cholesterol in plasma in a young man during experimental copper depletion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Dietary copper: a powerful determinant of cholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Comparative aspects of cardiac ultrastructure, morphometry, and electrocardiography of hearts from rats fed restricted dietary copper and selenium

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Decrease of cytochrome c oxidase protein in heart mitochondria of copper-deficient rats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Copper deficiency and heart disease: molecular basis, recent advances and current concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

A low plasma selenium is a risk factor for peripartum cardiomyopathy. A comparative study in Sahelian Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Cardiomyopathy associated with nonendemic selenium deficiency in a Caucasian adolescent

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Selenium in cardiology and angiology

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Decreased ubiquinone levels in tissues of rats deficient in selenium

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Evidence for altered structure and impaired mitochondrial electron transport function in selenium deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Selenium-based antihypertensives. Rationale and potential

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Beta-carotene intake and risk of nonfatal acute myocardial infarction in women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Altered contractile properties of rat cardiac muscle during experimental thiamine deficiency and food deprivation.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Furosemide-induced thiamine deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Furosemide and digoxin inhibit thiamine uptake in cardiac cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Thiamin status, diuretic medications, and the management of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Clinical relevance of thiamine status amongst hospitalized elderly patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Thiamine deficiency in hospitalized elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Riboflavin deficiency in infants and children with heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Homocysteine and coronary artery disease in French Canadian subjects: relation with vitamins B12, B6, pyridoxal phosphate, and folate

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Homocysteinemia due to folate deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Serum Folate and Risk of Fatal Coronary Heart Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Vitamin C deficiency and risk of myocardial infarction: prospective population study of men from eastern Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Protection from oxidized LDL-induced leukocyte adhesion to microvascular and macrovascular endothelium in vivo by vitamin C but not by vitamin E

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Treatment of hypertension with ascorbic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Antioxidant vitamin C improves endothelial dysfunction in chronic smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

The influence of smoking on vitamin C status in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Long-Term Ascorbic Acid Administration Reverses Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Vitamin E consumption and the risk of coronary heart disease in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Vitamin E consumption and the risk of coronary disease in women.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

The influence of antioxidant nutrients on platelet function in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Platelet function in type I diabetes: effects of supplementation with large doses of vitamin E

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Vascular incorporation of alpha-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Molecular basis of alpha-tocopherol control of smooth muscle cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

alpha-Tocopherol protects against expression of adhesion molecules on neutrophils and endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Combined treatment with vitamins E and C in experimental myocardial infarction in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

The cooperative interaction between vitamin E and vitamin C in suppression of peroxidation of membrane phospholipids

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Oxy free radical system in heart failure and therapeutic role of oral vitamin E.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Usefulness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival-3)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Effects of vitamin E on endothelial function in men after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Vitamin E supplementation and cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Statistical data support prediction of death within 6 months on low levels of coenzyme Q10 and other entities

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure. CoQ10 Drug Surveillance Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Noninvasive evaluation of cardiac hemodynamics during exercise in patients with chronic heart failure: effects of short-term coenzyme Q10 treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure. The Q10 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

The effect of coenzyme Q10 in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Ubiquinone (coenzyme Q10) in the long-term treatment of idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Plasma homocysteine levels and mortality in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Vitamin status and intake as primary determinants of homocysteinemia in an elderly population

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Arterial endothelial barrier dysfunction: actions of homocysteine and the hypoxanthine-xanthine oxidase free radical generating system

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Lipid peroxidation in homocysteinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Lipid peroxidation and susceptibility of low-density lipoprotein to in vitro oxidation in hyperhomocysteinaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Homocysteine redox receptor and regulation of extracellular matrix components in vascular cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats In vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Acute and chronic effects of propionyl-L-carnitine on the hemodynamics, exercise capacity, and hormones in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Effect of L-carnitine on myocardial metabolism: results of a balanced, placebo-controlled, double-blind study in patients undergoing open heart surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Anti-ischaemic efficacy of L-propionylcarnitine--a promising novel metabolic approach to ischaemia?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Additional antiischemic effects of long-term L-propionylcarnitine in anginal patients treated with conventional antianginal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Effects of L-propionylcarnitine on ischemia-induced myocardial dysfunction in men with angina pectoris.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

A randomised, double-blind, placebo-controlled trial of L-carnitine in suspected acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

L-Propionylcarnitine Effect on Postexercise and Postischemic Hyperemia in Patients Affected by Peripheral Vascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Study on propionyl-L-carnitine in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Exercise limitation in chronic heart failure: central role of the periphery

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

Skeletal muscle alterations in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901227-X

7 January 2021

10.1016/S0735-1097(01)01227-X

Identifiers

DOI

1 reference

1 August 2017

1 reference